LFSA Medical Advisory Board Member Dr. David Malkin and his team at SickKids in Toronto continue to improve the lives of those with Li-Fraumeni syndrome!
A recent article discusses a groundbreaking study led by researchers at SickKids Hospital, demonstrating the effectiveness of liquid biopsy in enhancing early cancer detection and diagnosis for patients with Li-Fraumeni syndrome (LFS). Li-Fraumeni syndrome predisposes individuals to various cancers from an early age. Liquid biopsy, a minimally invasive procedure, involves analyzing blood samples for tumor DNA, providing valuable insights into cancer progression and treatment response. The study’s findings underscore the potential of liquid biopsy as a powerful tool in personalized cancer management, offering hope for improved outcomes and quality of life for LFS patients.
Read more here!
